Dr. Abhineet Uppal, MD

Dr. Uppal practices at Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University.

Dr. Uppal's NPI, 1841511219, was assigned on June 18, 2010. Dr. Uppal graduated from University of North Carolina at Chapel Hill School of Medicine in 2010. Dr. Uppal holds Texas license S7359.

Dr. Uppal's primary practice is Emory University Hospital Midtown, at 550 Peachtree Street, NE, Atlanta, GA 30308 in Fulton County. The practice phone is (404) 686-2450.

Dr. Uppal's primary practice is Emory University Hospital Midtown in Atlanta, Georgia, part of Emory University. Dr. Uppal is also affiliated with Emory Saint Joseph's Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Uppal to 2 more hospitals, 1 clinical lab and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uppal practices, 5 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Uppal's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dmand AI has Dr. Uppal's licenses on file in 4 states: Texas, California, Georgia and Illinois.

CMS data shows 92 Medicare services from Dr. Uppal across 3 procedure codes in 2024, for 97 Medicare patients. Medicare paid $5,253 for them.

CMS counts 97 Medicare patients who saw Dr. Uppal in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have cancer, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Uppal's median patient age at 66, with 49% women.

In 2024, Dr. Uppal wrote 52 Medicare Part D claims for 17 patients. 71% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $8,773 in total drug cost. In 2017, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Uppal for performance year 2024, reported through an alternative payment model (APM). Dr. Uppal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Uppal as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 50 papers to Dr. Uppal, published from 2013 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Colorectal Neoplasms, Adenocarcinoma and Biomarkers, Tumor. Dr. Uppal has published most often in Ann Surg Oncol. Dr. Uppal's most frequent co-authors are George J. Chang, MD, Neal Bhutiani, MD, PhD and Brian K. Bednarski, MD.

CMS Open Payments shows 16 general payments to Dr. Uppal from 9 drug and device companies from 2017 to 2023. Consulting fees make up the largest share, 64% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $1,631.

Dr. Uppal graduated from University of North Carolina at Chapel Hill School of Medicine in 2010.